Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
VEGFR2 kinase inhibitor IV is an inhibitor of VEGFR2 (IC50 = 19 nM).1 It is greater than 100-fold selective for VEGFR2 over FGFR1 and Src but only 1.8-, 10-, and 10-fold selective over PDGFRβ, FLT1, and FLT2, respectively. VEGFR2 kinase inhibitor IV inhibits mitogenesis in human umbilical vein endothelial cells (HUVECs; IC50 = 387 nM). It also reduces VEGF-induced increases in neuroglobin levels in primary mouse cerebrocortical neurons when used at a concentration of 20 nM.2
WARNING This product is not for human or veterinary use.
1. Synthesis and initial SAR studies of 3,6-
2. Interactions between vascular endothelial growth factor and neuroglobin. Neurosci. Lett. 519(1), 47-50 (2012).